Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/JHC.S116513 http://scihub22266oqcxt.onion/10.2147/JHC.S116513 C5108608!5108608 !27878117     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27878117 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Hepatocell+Carcinoma 2016 ; 3 (ä): 63-67 Nephropedia Template TP {{tp|p=27878117 |t=2016. GPC-3 in hepatocellular carcinoma: current perspectives |pdf=|usr=}}{{27878117 }} gab.com Text GPC-3 in hepatocellular carcinoma: current perspectives JO: J Hepatocell Carcinoma http://www.kidney.de/pget.php?&tw=1&pmid=27878117 #FOAvip Glypican-3 (GPC3), a member of heparan sulfate proteoglycans, attaches to the cell membrane and is frequently observed to be elevated in hepatocellular carcinoma (HCC). However, GPC3 is not detected in normal liver tissues and benign liver lesions. Consequently, GPC3 is currently being used as a diagnostic biomarker and HCC-specific positron emission computed tomography probe to identify HCCs in normal liver tissues and benign liver lesions. The overexpression of GPC-3 in serum or liver tissue also predicts poor prognosis for HCC patients. In addition, GPC3 promotes HCC growth and metastasis by activating the canonical Wnt and other signaling pathways. Targeting of GPC3, including GC33, HN3 and YP7, might offer new immunotherapeutic tools for HCC treatment. Twit Text FOAVip GPC-3 in hepatocellular carcinoma: current perspectives ????J Hepatocell Carcinoma http://www.kidney.de/pget.php?&tw=1&pmid=27878117 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27878117 #FOAvip English Wikipedia <ref>{{Cite pmid|27878117 }}</ref> GPC-3 in hepatocellular carcinoma: current perspectives #MMPMID27878117 Wu Y ; Liu H ; Ding H J Hepatocell Carcinoma 2016[]; 3 (ä): 63-67 PMID27878117 show ga Glypican-3 (GPC3), a member of heparan sulfate proteoglycans, attaches to the cell membrane and is frequently observed to be elevated in hepatocellular carcinoma (HCC). However, GPC3 is not detected in normal liver tissues and benign liver lesions. Consequently, GPC3 is currently being used as a diagnostic biomarker and HCC-specific positron emission computed tomography probe to identify HCCs in normal liver tissues and benign liver lesions. The overexpression of GPC-3 in serum or liver tissue also predicts poor prognosis for HCC patients. In addition, GPC3 promotes HCC growth and metastasis by activating the canonical Wnt and other signaling pathways. Targeting of GPC3, including GC33, HN3 and YP7, might offer new immunotherapeutic tools for HCC treatment. äGPC-3 in hepatocellular carcinoma: current perspectives (epmc).pdf DeepDyve Pubget Overpricing